StockNews.com Begins Coverage on Bio-Path (NASDAQ:BPTH)

StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note issued to investors on Saturday morning. The firm issued a sell rating on the stock. Bio-Path Trading Down 6.0 % Bio-Path stock opened at $0.55 on Friday. Bio-Path has a 1-year low of $0.32 and a 1-year high of $2.35. […]

Leave a Reply

Your email address will not be published.

Previous post Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated by Analysts at StockNews.com
Next post Argentina November 2023: Nissan (+53.1%), Volkswagen (+47.7%) impress